MEDVi vs Novi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated September 3, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Novi scores higher on our rubric, 7.8/10 against 5.7/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit MEDVi - $179 first month, then $299/mo →or find your match

Novi beats MEDVi overall, scoring 7.8/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Novi is from $88/mo. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepatide at a low monthly rate and can accept a three-month commitment charged upfront.

A side-by-side look at MEDVi and Novi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

MEDVi

#42 of 54

5.7/10

MEDVi offers a weekly compounded GLP-1 injection and a daily compounded tablet. The injection is $179 for month one and $299 for refills. Trustpilot is 4.3 out of 5 across 14,680 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.

Visit MEDVi

Higher Rated

Novi

#8 of 54

7.8/10

Telehealth platform for compounded semaglutide and tirzepatide that also lists brand-name Mounjaro, Ozempic, Wegovy and Zepbound in stock from $1500. Pricing is published per billing cycle on the product pages: compounded semaglutide at $149 for one month, $130 for three, $129 for six and $88 for twelve; compounded tirzepatide at $179, $149, $133 and $129 across the same cycles. The monthly price covers the consultation, medication, supplies, shipping and unlimited physician messaging, and it does not change with the dose. The homepage advertises "Cancel anytime", but the terms of service require a minimum three-month commitment charged upfront and called non-refundable.

Visit Novi

Feature	MEDVi	Novi
Why each one	A daily dissolvable GLP-1 tablet and a weekly compounded injection in one program, plus brand-name Wegovy and Zepbound on a $99 membership.	One of the cheapest published compounded rates in the category, $88/mo for semaglutide and $129/mo for tirzepatide on a twelve-month cycle, on a site that also stocks brand-name Mounjaro, Ozempic, Wegovy and Zepbound from $1500. The price is real. So is the three-month commitment charged upfront that the homepage does not mention.
Our Score	5.7/10	7.8/10
Headline Price	$179 first month, then $299/mo	from $88/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Users who want both oral and injectable compounded options in one telehealth program	Cash-pay patients who want compounded semaglutide or tirzepatide at a low monthly rate and can accept a three-month commitment charged upfront
Watch out for	FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication	The homepage advertises "Cancel anytime" and "No monthly membership", but the terms of service require a minimum three-month commitment with all three months charged at purchase and called non-refundable
Ranking	#42	#8
Get started	Visit MEDVi	Visit Novi

Pros & Cons Compared

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+The landing page says the program is HSA and FSA eligible and includes dietician visits and care coaching, with a footnote making that subject to insurance and copay eligibility
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179 covers the first month of compounded semaglutide on MEDVi's landing page, including physician review, the personalized plan, medication and free shipping

Cons

−FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
−Its third-party records conflict: 4.3 out of 5 across 14,680 Trustpilot reviews with 12 percent of them at one star, against an F and no accreditation at the BBB
−The $179 semaglutide price covers month one only; the FAQ on MEDVi's own landing page says refills are locked in at $299 a month, making the first year $3,468 rather than $2,148
−Brand-name Wegovy and Zepbound paths add a $99 membership plus a medication cost the page does not publish, and the same page's hero says "No membership or hidden fees!" directly above those cards; availability is subject to change
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Novi

Pros

+Compounded and brand-name GLP-1s in one catalogue: compounded semaglutide and tirzepatide with published rates, plus Mounjaro, Ozempic, Wegovy and Zepbound listed in stock from $1500
+Serves all 50 states and Washington DC, with a short video or audio visit required only in Kansas, Louisiana, Mississippi, New Mexico and West Virginia
+Per cycle prices are printed on the product pages instead of hidden behind the quiz: compounded semaglutide at $149 for one month, $130 for three, $129 for six and $88 for twelve
+Unlimited physician messaging, follow-ups and dose adjustments through the online portal, with consultation, supplies and shipping included in the monthly price and the same price at every dose
+Free 2-day shipping; Novi markets compounded semaglutide and tirzepatide, which are not FDA-approved brands or generics and are not established as equivalent to Wegovy, Ozempic, Mounjaro, or Zepbound
+On-time refills shipped every 28 days after a short check-in, with free discreet delivery quoted at two to three business days on the product pages

Cons

−The homepage advertises "Cancel anytime" and "No monthly membership", but the terms of service require a minimum three-month commitment with all three months charged at purchase and called non-refundable
−The only address Novi shows is a Sheridan, Wyoming mailing suite used by large numbers of registered LLCs, the terms name Novi International LLC in one place and Novi Health LLC in the arbitration clause, and no founding year is shown on its terms, privacy or FAQ pages (rendered check 2026-09-03)
−The cheapest advertised rates need the longest billing cycle: compounded semaglutide is $88/mo on the twelve-month cycle but $149/mo on the one-month cycle, and compounded tirzepatide runs $129/mo to $179/mo the same way
−The refund policy says Novi is "unable to accept returns", while the product pages advertise a Progress Promise full refund and point to the terms of service for the details; "Progress Promise" is not shown anywhere on that terms page (rendered check 2026-09-03)
−Lab requirements before prescribing are not disclosed on public pages, unclear whether baseline bloodwork is required
−The headline price on the homepage changes with screen width, $133/mo on a desktop and $99/mo on a phone at the same address, and it sits beside a countdown that restarts on every page load

Our Verdict

Novi edges out MEDVi with a score of 7.8/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Novi is from $88/mo.